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Transcription-factor-driven direct reprogramming allows lineage conversion of somatic cells that bypasses
an intermediate pluripotent state. In this issue of Cell Stem Cell, Pereira et al. (2013) report the induction of
cells with hemogenic potential frommurine fibroblasts, an important step toward generating patient-specific
hematopoietic (stem) cells for clinical application.Many degenerative and malignant dis-
eases could be therapeutically targeted
by cell replacement strategies. These,
however, require large amounts of ideally
autologous cells for transplantation.
In 2006, Shinya Yamanaka’s ground-
breaking studies on induced pluripotent
stem cells (iPSCs) galvanized transcrip-
tion factor (TF)-mediated cell fate conver-
sion (Takahashi and Yamanaka, 2006).
This concept had already been intro-
duced more than a decade earlier by the
pioneering work of Davis, Weintraub,
and Lassar, who induced a myogenic
program in fibroblasts through forced
expression of MyoD, and by Graf and
colleagues, who converted myelomono-
cytic cells into eosinophils, thrombo-
blasts, and erythroblasts by ectopic
expression of Gata1 (reviewed in Graf,
2011). Consequently, direct reprogram-
ming, which allows lineage conversion of
a somatic cell without it passing through
an intermediate pluripotent state, has
become a fascinating way to generate
suitable cell sources for replacement
strategies. Encouraged by Yamanaka’s
approach, Vierbuchen et al. demon-
strated reprogramming of mouse fibro-
blasts into functional neurons (iNs)
by overexpression of Ascl1, Brn4, and
Myt1l, whereas ectopic expression of
other TF combinations resulted in an
oligodendrocytic fate. Meanwhile, other
studies reporting the generation of deriva-
tives from endoderm (hepatic cells, iHeps)
or mesoderm (cardiomyocytes, iCMs)
showed that direct reprogramming strate-
gies are not restricted to the neuroecto-
dermal lineage (summarized in Ladewig
et al., 2013 and Figure 1). Regarding cellreplacement therapies, the direct genera-
tion of progenitor cells, such as neural
stem cells, might be more appealing. In
contrast to terminally differentiated cells,
progenitors usually exhibit a robust self-
renewal capacity and may give rise to
various, more specified cell types upon
differentiation in a tissue-specific context
(reviewed in Zhou and Tripathi, 2012).
In this issue of Cell Stem Cell, Pereira
et al. now report TF-driven direct reprog-
ramming of murine fibroblasts into cells
with hemogenic potential. For many ma-
lignant and congenital blood diseases
hematopoietic stem cell transplantation
is the only curative option. Success of
this therapy, however, is curtailed by a
shortage of immunocompatible donor
cells and potential severe adverse effects
like graft-versus-host disease. Here, the
generation of autologous hematopoietic
stem or progenitor cells appears as a
captivating strategy. Since the generation
of patient-specific hematopoietic stem
cells (HSCs) from iPSCs has not been
accomplished as of yet, directly reprog-
ramming somatic into hematopoietic cells
represents a very attractive alternative
approach. The authors selected 18 candi-
date TFs from the expression profile of
slowly dividing HSCs and tested their abil-
ity to induce a hemogenic program in
murine fibroblasts. An hCD34-driven his-
tone 2B-GFP fusion protein (H2BGFP),
shown previously to allow visualization
of long-term repopulating murine HSCs
and endothelial cells, was employed as
a reporter system. After simultaneous
transduction with all 18 TFs from retroviral
constructs and under hematopoiesis-
supporting conditions (coculture with theCell Stem Cell 1stroma cell line AFT024 and supplemen-
tation with SCF, Flt3L, Il-3, and Il-6), fibro-
blasts gave rise to H2BGFP+ cells 21 days
posttransduction (p.t.). To identify the TFs
essential for hemogenic reprogramming,
the authors gradually omitted factors
and found Gata2, Gfi1b, and cFos to be
crucial and Etv6 as strongly supportive
for hemogenic reprogramming. Intrigu-
ingly, this particular factor combination
might not necessarily reflect the key
network of HSC regulation. On the other
hand, each of these factors has been
shown to be of tremendous importance
for proper hematopoietic development,
and this is particularly true for Gata2,
which is generally accepted as one of
the major forces driving embryonic devel-
opment of the hematopoietic system.
Interestingly, the combination of only
Gata2, Gfi1b, cFos, and Etv6 rendered
hemogenic reprogramming independent
of stroma and cytokine support. Tran-
scriptome analysis revealed profound
changes in gene expression, with fibro-
blast-specific genes being downregulated
and hematopoiesis-related genes being
upregulated in the first 20daysp.t. After 20
additional days of culture, reprogrammed
cells further established a hematopoietic
expression profile and expressed genes
such as Csfr, Il3r, CD43, cKit, Mpl, CD45,
and CD41. Intriguingly, at this stage the
cells also coexpressed markers of endo-
thelial progenitor cells (Vwf, Nos3, and
Id1) and hemogenic endothelium (Runx1
and Etv2) together with markers of
fetal hematopoiesis (CD93/AA4.1, CD41,
and Sox17). When the authors investi-
gated the expression profile of the
emerging GFP+ cells in more detail, a3, August 1, 2013 ª2013 Elsevier Inc. 131
Figure 1. Fibroblast-Derived Members of the iClub
Ectopic expression of transcription factors allows reprogramming of fibroblasts into cells of other lineages, such as induced pluripotent stem cells (iPSCs),
induced cardiomyocytes (iCM), induced neurons (iN), induced neural stem cells (iNSCs), induced hepatic cells (iHep), and induced hematopoietic cells
(iHem). SpecificmicroRNAs (miRs) have also been described to support the generation of iPSCs, iCMs, and iNs. Experimental evaluation proved full pluripotency
of iPSCs in various assays and demonstrated functionality of iCMs, iNs, iNSCs, and iHeps in vitro or in vivo. iHems, as generated by Pereira et al. (2013), give rise
to distinct hematopoietic cells, and future studies have to assess whether they exhibit bona fide HSC multipotency.
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enriched for cells with hemogenic poten-
tial, became apparent. This Sca1+/
Prominin1+ population exhibited an endo-
thelial-like transcriptome signature at day
20 p.t. before it switched to a more
hematopoietic program during the next
15–20 days. These results are in line
with previous reports on murine embry-
onic hematopoietic development, which
demonstrated that hematopoietic cells
arise from a progenitor with both hemato-
poietic and endothelial potential, hence
the term ‘‘hemogenic endothelium’’ (Bois-
set et al., 2010). When Pereira et al. inte-
grated the gene expression profile of their
day 35 CD45+ cells (‘‘iHem’’) into the array
data set from McKinney-Freeman et al.
(2012), a substantial overlap in the expres-
sion profiles of iHems and cells from the
murine aorta-gonado-mesonephros re-
gion (AGM) and placenta (E12.5) became
apparent.
The relatively long time it takes to
establish a hematopoietic-like transcrip-
tome signature suggests that the optimal
factor combination for direct hemogenic
reprogramming might not have been132 Cell Stem Cell 13, August 1, 2013 ª2013identified yet, especially when consid-
ering the kinetics of iPSCs, iNs, or iCMs.
Studies with iPSCs or iNs have revealed
that other factors, such as small-molecule
inhibitors or microRNAs, can profoundly
increase reprogramming efficiencies (re-
viewed in Pfaff et al., 2012 and Figure 1).
However, not only the combination of
transcription factors but also their stoichi-
ometry has been demonstrated to greatly
influence the yield of reprogrammed
cells, and very recent data on iPSCs also
suggests that a sequential rather than
combined expression of reprogramming
factors is preferential to achieve greater
reprogramming efficiencies (Liu et al.,
2013).
Notwithstanding the molecular proper-
ties of a reprogrammed cell, its biological
significance is primarily determined by
functionality (Figure 1). For iPSCs, plurip-
otency is unequivocally demonstrated by
the application of tetraploid embryo ag-
gregation assays, and this level of strin-
gency has even been applied in the case
of disease-specific iPSCs corrected by
lentiviral gene transfer (Wu et al., 2011).
For other members of the ‘‘iClub’’ (iCMs,Elsevier Inc.iNs, iNSCs, and iHeps), less stringent
tests have been applied, which never-
theless have indicated functionality
in vitro or in vivo upon transplantation.
Pereira et al. now demonstrate the gener-
ation of hematopoietic cells with a sur-
face phenotype (CD45+/c-Kit+/CD48/
CD150+) resembling that of in vivo LT-
HSCs (Lin/Sca1+/c-Kit+/CD48/150+).
These cells give rise to hemogenic col-
onies containing myeloid lineage cells in
a modified methylcellulose assay upon
being cocultivated with irradiated mouse
placental cells. Here, follow-up studies
should demonstrate the potential of
iHems to also generate cells of erythroid,
megakaryocytic, and, in particular,
lymphoid lineage. Ideally, long-term repo-
pulation and serial transplantation studies
would irrevocably demonstrate properties
of bona fide HSCs.
Future therapeutic strategies employ-
ing induced hematopoietic cells also call
for reprogramming of human cells and
scaling up the culture conditions to
achieve cell yields that would meet the
requirements of hematopoietic cell ther-
apy. Nevertheless, taking into account
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elucidate some of the extremely complex
molecular mechanisms underlying the
generation of iPSCs and to considerably
increase the efficiency of this process,
the findings of Pereira et al. represent an
important step toward the individualized
generation of hematopoietic (stem) cells.
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Tet proteins and DNA demethylation are key regulators of embryonic stem cells, but their roles in develop-
ment and tissue stem cells remain unclear. In this issue, Zhang et al. (2013) show that Tet1 regulates adult
hippocampal neurogenesis by controlling progenitor proliferation, and Tet1 deficiency generates defects
in learning and memory.Five decades ago it was first demon-
strated that newborn neurons are gener-
ated from stem cells in the adult brain
throughout life. These newborn neurons
then integrate into the existing neuronal
circuitry and contribute to learning and
memory in the dentate gyrus of the hippo-
campus (Go¨ritz and Frise´n, 2012). In this
issue of Cell Stem Cell, Zhang et al.
(2013) now describe a new player in this
process. Though most of the stem cells
in the brain are usually nonproliferating
or quiescent, like runners at the starting
line of a race, they become activated in
cohorts to proliferate, undergo neurogen-
esis, and generate newborn neurons (see
Figure 1).
Zhang et al. now show that Tet proteins
control the decision of neural stem and
progenitor cells (NSPCs) to proliferate
and undergo neurogenesis. Tet proteins
can catalyze the addition of covalent
hydroxyl modifications to methylated
DNA (hydroxymethylation). DNA methyl
hydroxylation is associated with activa-
tion of genes and is thought to be a keyintermediate in the demethylation pro-
cess. Robust levels of Tet proteins and
5hmC are found in embryonic stem cells
and in the adult central nervous system.
Recent studies suggest that in embryonic
stem cells, Tet1 maintains an active state
of gene expression and surprisingly, in
combination with Prc2 and Sin3a, main-
tains a bivalent or poised gene activation
state (Williams et al., 2011; Wu et al.,
2011). The biological role of Tet1 and
5hmC, however, remained to be deci-
phered in the developing and adult ner-
vous system.
Zhang et al. generated both conven-
tional knockouts (KO) and conditional
knockouts (cKO) of Tet1 in mice to
elucidate the role of Tet1 in the central
nervous system and surprisingly re-
vealed a function for Tet1 in learning
and memory. Tet1 KO mice did not
show any defects in fertility, growth, or
early development, consistent with pre-
vious work (Dawlaty et al., 2013). Inter-
estingly, Tet1 mutant mice did display
defects in spatial learning as well asshort-term memory loss when chal-
lenged in the Morris water maze, a sys-
tem commonly used to test these abili-
ties. Due to the well-described role for
hippocampal neurogenesis in learning
and memory (Deng et al., 2010), the
authors next examined the effects of
Tet1 deletion on hippocampal NSPCs
in vitro. They observed decreased prolif-
eration of NSPCs from Tet1 KO mice,
with no obvious change in lineage-spe-
cific differentiation.
To understand the requirement for
Tet1 in adult hippocampal neurogenesis,
the authors next generated Nestin-Cre-
ERT2 Tet1 cKO mice. They found that
deleting Tet1 specifically in adult NSPCs
in vivo decreases their proliferation.
Lineage tracing also showed that this
loss in proliferation led to a decrease
in newly generated neurons. However,
the authors did not subject the Tet1
cKO mice to behavioral testing, leaving
open the question of whether the
observed decrease in proliferation of
NSPCs and decreased generation of3, August 1, 2013 ª2013 Elsevier Inc. 133
